Next Article in Journal
Dielectron Production in Proton–Proton Collisions at √s =7 TeV with ALICE
Previous Article in Journal
Kaon Isospin Fluctuations in ALICE at the LHC
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Proceeding Paper

Preparation and Hydro-Lipophilic Properties of Methoxylated and Methylated 1-Hydroxynaphthalene-2-Carboxanilides †

1
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Comenius University, Odbojarov 10, 832 32 Bratislava, Slovakia
2
Department of Chemical Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Palackeho 1, 612 42 Brno, Czech Republic
3
Institute of Chemistry, University of Silesia, 75 Pulku Piechoty 1a, 41 500 Chorzow, Poland
4
Global Change Research Institute CAS, Belidla 986/4a, 603 00 Brno, Czech Republic
5
Central Laboratories, Faculty of Chemical and Food Technology, Slovak University of Technology in Bratislava, Radlinskeho 9, Bratislava 812 37, Slovakia
6
Department of Analytical Chemistry, Faculty of Natural Sciences, Comenius University, Ilkovicova 6, 842 15 Bratislava, Slovakia
7
Division of Biologically Active Complexes and Molecular Magnets, Regional Centre of Advanced Technologies and Materials, Faculty of Science, Palacky University, Slechtitelu 27, 783 71 Olomouc, Czech Republic
*
Author to whom correspondence should be addressed.
Presented at the 22nd International Electronic Conference on Synthetic Organic Chemistry, 15 November– 15 December 2018; Available Online: https://sciforum.net/conference/ecsoc-22.
Proceedings 2019, 9(1), 43; https://doi.org/10.3390/ecsoc-22-05660
Published: 14 November 2018

Abstract

:
A series of variously methoxylated and methylated N-aryl-1-hydroxynaphthalene-2-carboxanilides was prepared and characterized as potential anti-invasive agents. As it is known that lipophilicity significantly influences the biological activity of compounds, the hydro-lipophilic properties of these mono-, di- and tri-substituted 1-hydroxynaphthalene-2-carboxanilides are investigated in the study. All the discussed hydroxynaphthalene derivatives were analyzed using the reversed-phase, high-performance liquid chromatography method, to measure lipophilicity. The procedure was performed under isocratic conditions with methanol as an organic modifier in the mobile phase, using an end-capped, non-polar C18 stationary reversed-phase column. The present study discusses the correlations between the logarithm of the capacity factor k and log P/Clog P values, calculated in various ways, as well as the relationships between the lipophilicity and the chemical structure of the studied compounds.

1. Introduction

One of the major prerequisites for pharmacological screening and drug development is the prediction of absorption, e.g., the transport of a molecule through membranes. Drugs most frequently cross biological barriers by passive transport, which strongly depends on lipophilicity. Therefore, hydro-lipophilic properties are some of the most important physical characteristics of biologically- active compounds [1,2]. The thermodynamic parameter, characterized by the partition (log P) coefficient, describes the partitioning of a compound between an aqueous and an organic phase [3]. Classical methods for the determination of these constants are time-consuming and not always sufficiently reliable. Therefore, reversed-phase, high-performance liquid chromatography (RP-HPLC) methods have become popular and are widely used for lipophilicity measurements. A general procedure is the measurement of directly-accessible retention time, under isocratic conditions, with varying amounts of an organic modifier in the mobile phase, using end-capped, non-polar C18 stationary RP columns and calculating the capacity factor k [4,5,6,7,8,9]. Log k, calculated from the capacity factor k, is used as the lipophilicity index, and converted to log P scale [4].
Ring-substituted 1-hydroxynaphthalene-2-carboxanilides were recently synthesized and tested for their antibacterial and antimycobacterial activity, as well as for their activity related to the inhibition of photosynthetic electron transport (PET) in spinach (Spinacia oleracea L.) chloroplasts [10,11,12,13]. The new methoxy and methyl multisubstituted derivatives expand the spectrum of substitutions in the carboxanilide part of the molecule. As it was found that the lipophilicity of these significantly biologically-effective agents [10,11,12,13] determines their activity, this study investigated and compared the hydro-lipophilic properties of new methoxy and methyl multisubstituted 1-hydroxynaphthalene-2-carboxanilides with the hydro-lipophilic properties of recently-prepared monosubstituted N-alkoxy-1-hydroxy-naphthalene-2-carboxanilides and N-alkyl-1-hydroxy- naphthalene-2-carboxanilides. This contribution is a follow-up work to the previous papers [5,6,7,8,9,14,15,16,17,18,19,20,21,22,23,24] aimed at the investigation of the physicochemical properties of new, biologically-active agents.

2. Results and Discussion

The condensation of 1-hydroxynaphthalene-2-carboxylic acid with the appropriately substituted anilines, using phosphorus trichloride in dry chlorobenzene, under microwave conditions, gave a series of methoxylated and methylated N-aryl-1-hydroxynaphthalene-2-carboxanilides 117, as shown in Scheme 1.
The lipophilicities (log P/Clog P data) of all seventeen anilides were calculated using two commercially-available programs: ACD/Percepta, ver. 2012, and ChemBioDraw Ultra 13.0. In addition, the lipophilicity of the studied compounds was investigated by means of the RP-HPLC determination of capacity factors k, with a subsequent calculation of log k. The results are shown in Table 1.
Log P values, calculated by the ChemBioDraw software for individual anilide positional isomers, except for unsubstituted compound 1 and trisubstituted compounds 7 and 14, are not distinguished; therefore, these values are listed only in Table 1 without further discussion. Log P values of methylated ortho-, meta- and para-isomers/derivatives 810, 11/13 and 1517, calculated by ACD/Percepta, were not distinguished as well. Clog P values, calculated by ChemBioDraw, provided the best results; these parameters are not distinguished for isomers 3/4 (R = 3-OCH3, R = 4-OCH3) and isomers 9/10 (R = 3-CH3, R = 4-CH3), as can be seen in Table 1.
The conformity of the experimental and calculated log P (ACD) values of methoxylated derivatives are plotted in Figure 1, while the conformity of the experimental and calculated Clog P (ChemBioDraw) values of the substituted compounds are illustrated in Figure 2. Based on these results, it can be stated that log P (ACD) values for methoxy derivatives 27 have a good match with experimentally-determined log k (r = 0.8983, n = 6), as shown in Figure 1. In addition, log k versus Clog P of the methoxy derivatives have a poor match (r = 0.2793, n = 6), seen in Figure 2A, contrary to the dependence of log k on Clog P of methyl derivatives 814, that have an excellent match (r = 0.9709, n = 7), as can be seen in Figure 2B. A poor match (r = 0.6652, n = 3) can also be observed for methoxymethyl derivatives 1517, shown in Figure 2C. In general, these differences between the experimental results of log k and the calculated log P values can denote intramolecular interactions, i.e., influences of the spatially-close phenolic moiety, the amide moiety, and substituents on the anilide ring.
The experimental results of lipophilicity expressed as log k are much more interesting and probably, more realistically, plot the influence of individual substituents on the overall lipophilicity of the individually discussed derivatives. Compound 15 (R = 2-OCH3-5-CH3, log k = 1.0603) showed the highest lipophilicity, while the lowest lipophilicity was demonstrated by compound 16 (R = 2-OCH3-6-CH3, log k = 0.4574). In the middle of the log k values of these two compounds, unsubstituted derivative 1 (log k = 0.6769) can be found, as seen in Figure 3. Although slightly higher than that of compound 16, the second-lowest lipophilicity was observed for compound 17 (R = 5-OCH3-2-CH3). Based on these observations, it can be stated that the displacement of the methyl moiety from position 5 (meta) to 6 (ortho), or the preparation of “inverse” isomers (i.e., the elimination of the methoxy moiety from the ortho position; compare the compounds 15 and 17), led to a sharp decrease of lipophilicity, which supports a theory about intramolecular interactions among substituents that are spatially close (especially in the ortho position) to the amide bond (-CONH–) and the phenolic moiety.
Within the series of monomethoxylated derivatives, the determined log k values decrease as follows: 2-OCH3 (compound 2) >> 3-OCH3 (compound 3) > 4-OCH3 (compound 4); while, within the series of monomethylated derivatives, an opposite trend can be observed, i.e., the lipophilicity decreases as follows: 4-CH3 (compound 10) > 3-CH3 (compound 9) >> 2-CH3 (compound 8). Only the 2-OCH3 derivative showed a higher log k value than unsubstituted compound 1, while the 4-CH3 and 3-CH3 derivatives showed higher log k values than unsubstituted compound 1. 2,5-Dimethoxy derivative 5 possessed a higher log k value than compound 11 (R = 2,5-CH3). On the other hand, compound 6 (R = 3,5-OCH3) had a much lower log k value than compound 11 (R = 3,5-CH3). Also, trimethyl derivative 14 showed a much higher lipophilicity than trimethoxy derivative 7. In addition, 2,5-dimethoxy derivative 5 has a similar lipophilicity as monosubstituted 2-OCH3 (compound 2). In fact, the lipophilicity of di- and tri-methoxy derivatives decreases as follows: 2,5-OCH3 (compound 5) >> 3,5-OCH3 (compound 6) > 3,4,5-OCH3 (compound 7). These results also refer to the importance of ortho-placed methoxy moieties for the higher lipophilicity of the compounds. Among di- and tri-methyl substituted derivatives, the log k values decrease as follows: 3,5-CH3 (compound 13) >> 2,4,6-CH3 (compound 14) > 2,5-CH3 (compound 11) > 2,6-CH3 (compound 12). Contrary to the findings related to the methoxy moieties, meta and para substitution seems to be important for the higher lipophilicity of the methyl substituted derivatives.
Thus, it can be assumed that experimentally-determined log k values specify lipophilicity within the individual series of compounds more precisely, and can be used as a useful tool for further investigation of structure-activity relationships within these methoxy/methyl substituted series of biologically-active compounds.

3. Experimental Section

3.1. General

All reagents were purchased from Merck (Sigma-Aldrich, St. Louis, MO, USA) and Alfa (Alfa-Aesar, Ward Hill, MA, USA). Reactions were performed using a CEM Discover SP microwave reactor (CEM, Matthews, NC, USA). Thin layer chromatography was performed on alumina-backed silica gel 40 F254 plates (Merck, Darmstadt, Germany). The plates were illuminated under UV (254 nm) light and evaluated in iodine vapor. Melting points were determined on a Kofler hot-plate apparatus (HMK Franz Kustner Nacht BG, Dresden, Germany) and are uncorrected. The purity of the final compounds was checked by a Waters Alliance 2695 XE HPLC separation module (Waters Corp., Milford, MA, USA). A detection wavelength of 210 nm was used. The peaks in the chromatogram of the solvent (blank) were deducted from the peaks in the chromatogram of the sample solution. The purity of the individual compounds was determined from the area peaks in the chromatogram of the sample solution. Infrared (IR) spectra were recorded on a Smart MIRacle™ ATR ZnSe for a Nicolet™ Impact 410 FT-IR spectrometer (Thermo Scientific, West Palm Beach, FL, USA). The spectra were obtained by the accumulation of 64 scans with 2 cm−1 resolution in the region of 4000–650 cm−1. All 1H and 13C NMR spectra were recorded on an Agilent VNMRS 600 MHz system (600 MHz for 1H and 151 MHz for 13C; Agilent Technologies, Santa Clara, CA, USA) in DMSO-d6. Chemical shifts are reported in ppm (δ) using the signal of the solvent (DMSO-d6) as the reference (2.500, resp. 39.50) against the internal standard, Si(CH3)4. High-resolution mass spectra were measured using a Dionex UltiMate® 3000 high-performance liquid chromatograph (Thermo Scientific) coupled with a LTQ Orbitrap XLTM Hybrid Ion Trap-Orbitrap Fourier Transform Mass Spectrometer (Thermo Scientific), with an injection into a HESI-II Probe in the positive or negative mode.

3.2. Synthesis

General Procedure: 1-Hydroxynaphthalene-2-carboxylic acid (5.3 mmol), and the corresponding substituted aniline (5.3 mmol), were suspended in 30 mL of dry chlorobenzene. Phosphorous trichloride (2.65 mmol) was added dropwise, and the reacting mixture was heated using infrared flask-surface control of temperature at maximal allowed power 500 W and 130 °C in the microwave reactor for 15 min. The solvent was evaporated under reduced pressure. Subsequently, the solid residue was washed with 2 M HCl and the crude product was recrystallized from aqueous ethanol. All of the studied compounds are presented in Table 1.
Described anilides 14 and 810 were characterized recently by Gonec et al. [10].
N-(2,5-Dimethoxyphenyl)-1-hydroxynaphthalene-2-carboxamide (5). Yield 75%; Mp. 116–119 °C; HPLC purity 97.60%; IR (cm−1): 3433, 1634, 1604, 1595, 1538, 1489, 1453, 1413, 1387, 1325, 1276, 1248, 1208, 1200, 1172, 1150, 1125, 1045, 1021, 951, 866, 835, 806, 792, 762, 723, 711; 1H-NMR (DMSO-d6), δ: 13.66 (s, 1H), 10.34 (s, 1H), 8.33 (dd, 1H, J = 7.7, J = 1.3 Hz), 8.07 (d, 1H, J = 8.6 Hz), 7.91 (d, 1H, J = 8.1 Hz), 7.67 (ddd, 1H, J = 8.2, J = 6.9, J = 1.3 Hz), 7.59 (ddd, 1H, J = 8.3, J = 7.0, J = 1.2 Hz), 7.53 (d, 1H, J = 8.8 Hz), 7.43 (d, 1H, J = 2.9 Hz), 7.06 (d, 1H, J = 8.8 Hz), 6.81 (dd, 1H, J = 8.8, J = 2.9 Hz), 3.82 (s, 3H), 3.74 (s, 3H); 13C-NMR (DMSO-d6), δ: 168.20, 158.43, 152.92, 146.22, 135.97, 128.90, 127.58, 126.54, 125.90, 124.84, 123.62, 123.09, 118.42, 112.35, 111.51, 110.69, 108.95, 56.24, 55.48; HR-MS: [M − H]+ calculated 322.10739 m/z, found 322.10892 m/z.
N-(3,5-Dimethoxyphenyl)-1-hydroxynaphthalene-2-carboxamide (6). Yield 83%; Mp. 118–121 °C; HPLC purity 96.95%; IR (cm−1): 3266, 2999, 2936, 2833, 2540, 1614, 1595, 1549, 1514, 1470, 1453, 1423, 1332, 1296, 1257, 1227, 1194, 1154, 1064, 985, 846, 813, 799, 711; 1H-NMR (DMSO-d6), δ: 13.93 (s, 1H), 10.35 (s, 1H), 8.31 (d, 1H, J = 8.2 Hz), 8.11 (d, 1H, J = 9.2 Hz), 7.91 (d, 1H, J = 8.2 Hz), 7.67 (ddd, 1H, J = 8.0, J = 6.8, J = 1.3 Hz), 7.58 (ddd, 1H, J = 8.3, J = 7.0, J = 1.2 Hz), 7.47 (d, 1H, J = 8.9 Hz), 7.05 (d, 2H, J = 2.3 Hz), 6.36 (t, 1H, J = 2.3 Hz), 3.77 (s, 6H); 13C-NMR (DMSO-d6), δ: 169.49, 160.37, 159.91, 139.34, 135.99, 129.14, 127.47, 125.93, 124.65, 123.07, 123.01, 117.79, 107.60, 100.13, 96.69, 55.22; HR-MS: [M − H]+ calculated 322.10738 m/z, found 322.10788 m/z.
1-Hydroxy-N-(3,4,5-trimethoxyphenyl)-naphthalene-2-carboxamide (7). Yield 66%; Mp. 177–180 °C; HPLC purity 98.47%; IR (cm−1): 3375, 1627, 1594, 1549, 1504, 1452, 1410, 1393, 1328, 1293, 1278, 1230, 1210, 1186, 1127, 1001, 989, 950, 836, 825, 814, 793, 760, 725; 1H-NMR (DMSO-d6), δ: 14.01 (s, 1H), 10.36 (s, 1H), 8.31 (d, J = 8.1 Hz, 1H), 8.11 (d, J = 8.8 Hz, 1H), 7.92 (d, J = 8.1 Hz, 1H), 7.68 (t, J = 7.2 Hz, 1H), 7.56–7.61 (m, 1H), 7.47 (d, J = 8.8 Hz, 1H), 7.17 (s, 2H), 3.81 (s, 6H), 3.67 (s, 3H); 13C-NMR (DMSO-d6), δ: 169.29, 159.93, 152.63, 135.97, 134.56, 133.64, 129.13, 127.49, 125.94, 124.68, 123.08, 122.92, 117.78, 107.53, 99.84, 60.12, 55.86; HR-MS: for C20H19NO5 [M + H]+ calculated 354.133599 m/z found 354.13376 m/z.
N-(2,5-Dimethylphenyl)-1-hydroxynaphthalene-2-carboxamide (11). Yield 70%; Mp. 92–95 °C; HPLC purity 95.71%; IR (cm−1): 3445, 1627, 1575, 1538, 1447, 1410, 1387, 1358, 1330, 1286, 1246, 1209, 1025, 882, 840, 805, 791, 757; 1H-NMR (DMSO-d6), δ: 14.28 (br.s, 1H), 10.34 (s, 1H), 8.30 (dd, 1H, J = 7.7, J = 1.3, Hz), 8.10 (d, 1H, J = 8.6 Hz), 7.91 (d, 1H, J = 8.1 Hz), 7.67 (ddd, 1H, J = 8.2, J = 6.9, J = 1.3 Hz), 7.58 (ddd, 1H, J = 8.3, J = 7.0, J = 1.2 Hz), 7.46 (d, 1H, J = 8.9 Hz), 7.20 (d, 1H, J = 8.1 Hz), 7.17 (s, 1H), 7.06 (dd, 1H, J = 7.8, J = 1.3 Hz), 2.31 (s, 3H), 2.21 (s, 3H); 13C-NMR (DMSO-d6), δ: 169.57, 159.96, 135.96, 135.35, 134.93, 131.22, 130.22, 129.02, 127.76, 127.51, 127.50, 125.88, 124.70, 123.03, 122.94, 117.87, 107.16, 20.41, 17.35; HR-MS: [M − H]+ calculated 290.11756 m/z, found 290.11859 m/z.
N-(2,6-Dimethylphenyl)-1-hydroxynaphthalene-2-carboxamide (12). Yield 80%; Mp. 102–105 °C; HPLC purity 98.10%; IR (cm−1): 3413, 1615, 1587, 1577, 1508, 1493, 1408, 1379, 1325, 1274, 1247, 1203, 1147, 950, 877, 817, 795, 773, 765, 727, 714; 1H-NMR (DMSO-d6), δ: 14.36 (s, 1H), 10.26 (s, 1H), 8.29 (dd, 1H, J = 8.3, J = 1.0 Hz), 8.13 (d, 1H, J = 8.9 Hz), 7.92 (d, 1H, J = 8.2 Hz), 7.67 (ddd, 1H, J = 8.2, J = 6.9, J = 1.3 Hz), 7.57 (ddd, 1H, J = 8.2, J = 6.9, J = 1.3 Hz), 7.46 (d, 1H, J = 8.8 Hz), 7.18 (s, 3H), 2.22 (s, 6H); 13C-NMR (DMSO-d6), δ: 169.57, 160.10, 135.96, 135.69, 134.09, 129.04, 127.87, 127.51, 127.25, 125.91, 124.71, 123.00, 122.76, 117.90, 106.78, 17.92; HR-MS: [M − H]+ calculated 290.11756 m/z, found 290.11847 m/z.
N-(3,5-Dimethylphenyl)-1-hydroxynaphthalene-2-carboxamide (13). Yield 69%; Mp. 88–90 °C; HPLC purity 94.30%; IR (cm−1): 3420, 1614, 1579, 1543, 1465, 1412, 1388, 1355, 1327, 1280, 1243, 1206, 1183, 864, 840, 803, 755, 726, 685; 1H-NMR (DMSO-d6), δ: 14.10 (br. s, 1H), 10.33 (s, 1H), 8.31 (d, 1H, J = 8.2 Hz), 8.12 (d, 1H, J = 8.9 Hz), 7.91 (d, 1H, J = 8.2 Hz), 7.67 (ddd, 1H, J = 8.2, J = 6.9, J = 1.3 Hz), 7.58 (ddd, 1H, J = 8.2, J = 6.9, J = 1.3 Hz), 7.45 (d, 1H, J = 8.9 Hz), 7.37 (s, 2H), 6.84 (s, 1H), 2.30 (s, 6H); 13C-NMR (DMSO-d6), δ: 169.37, 159.96, 137.66, 137.37, 135.94, 129.07, 127.44, 126.26, 125.87, 124.65, 123.04, 123.01, 119.84, 117.75, 107.51, 21.00; HR-MS: [M − H]+ calculated 290.11756 m/z, found 290.11917 m/z.
1-Hydroxy-N-(2,4,6-trimethylphenyl)-naphthalene-2-carboxamide (14). Yield 52%; Mp. 160–163 °C; HPLC purity 100%; IR (cm−1): 3306, 1616, 1590, 1520, 1498, 1456, 1409, 1383, 1320, 1277, 1255, 1210, 1141, 1081, 1033, 1021, 946, 933, 844, 799, 765, 716, 708, 667; 1H-NMR (DMSO-d6), δ: 14.40 (s, 1H), 10.15 (s, 1H), 8.29 (d, J = 8.1 Hz, 1H), 8.12 (d, J = 8.8 Hz, 1H), 7.91 (d, J = 8.3 Hz, 1H), 7.67 (t, J = 7.5 Hz, 1H), 7.55–7.60 (m, 1H), 7.45 (d, J = 8.8 Hz, 1H), 6.98 (s, 2H), 2.28 (s, 3H), 2.17 (s, 6H); 13C-NMR (DMSO-d6), δ: 169.66, 160.09, 136.29, 135.94, 135.30, 131.44, 129.00, 128.47, 127.50, 125.88, 124.74, 123.00, 122.78, 117.85, 106.83, 20.54, 17.86; HR-MS: for C20H19NO2 [M − H]+ calculated 304.133205 m/z found 304.13416 m/z.
1-Hydroxy-N-(2-methoxy-5-methylphenyl)-naphthalene-2-carboxamide (15). Yield 74%; Mp. 106–108 °C; HPLC purity 99.62%; IR (cm−1): 3433, 1627, 1592, 1539, 1488, 1436, 1411, 1387, 1361, 1322, 1285, 1275, 1249, 1207, 1172, 1149, 1120, 1033, 1022, 938, 874, 800, 790, 759, 726; 1H-NMR (DMSO-d6), δ: 13.92 (s, 1H), 10.23 (s, 1H), 8.31 (d, J = 8.1 Hz, 1H), 8.07 (d, J = 8.8 Hz, 1H), 7.91 (d, J = 8.3 Hz, 1H), 7.66 (ddd, J = 8.2, 6.9, 1.4 Hz, 1H), 7.56–7.60 (m, 1H), 7.49 (d, J = 1.8 Hz, 1H), 7.46 (d, J = 8.8 Hz, 1H), 7.01–7.08 (m, 2H), 3.82 (s, 3H), 2.29 (s, 3H); 13C-NMR (DMSO-d6), δ: 168.74, 159.06, 150.54, 135.99, 129.16, 128.98, 127.61, 127.15, 126.59, 125.93, 125.23, 124.84, 123.42, 123.12, 118.22, 111.54, 108.34, 55.79, 20.24; HR-MS: for C19H17NO3 [M + H]+ calculated 308.12812 m/z found 308.12842 m/z.
1-Hydroxy-N-(2-methoxy-6-methylphenyl)-naphthalene-2-carboxamide (16). Yield 58%; Mp. 177–179 °C; HPLC purity 99.96%; IR (cm−1): 3400, 1616, 1595, 1575, 1511, 1498, 1472, 1412, 1389, 1328, 1309, 1267, 1252, 1208, 1147, 1080, 1033, 1023, 946, 846, 802, 791, 771, 759, 730, 720; 1H-NMR (DMSO-d6), δ: 14.40 (s, 1H), 10.07 (s, 1H), 8.29 (d, J = 8.2 Hz, 1H), 8.12 (d, J = 8.8 Hz, 1H), 7.91 (d, J = 8.3 Hz, 1H), 7.65–7.69 (m, 1H), 7.55–7.60 (m, 1H), 7.45 (d, J = 8.8 Hz, 1H), 7.25 (t, J = 8.0 Hz, 1H), 6.97 (d, J = 8.1 Hz, 1H), 6.92 (d, J = 7.6 Hz, 1H), 3.77 (s, 3H), 2.20 (s, 3H); 13C-NMR (DMSO-d6), δ: 169.80, 160.06, 155.24, 137.03, 135.93, 129.00, 128.01, 127.50, 125.87, 124.71, 123.73, 123.01, 122.98, 121.98, 117.77, 109.31, 106.96, 55.60, 17.68; HR-MS: for C19H17NO3 [M + H]+ calculated 308.12812 m/z found 308.12842 m/z.
1-Hydroxy-N-(5-methoxy-2-methylphenyl)-naphthalene-2-carboxamide (17). Yield 60%; Mp. 128–130 °C; HPLC purity 98.88%; IR (cm−1): 3317, 1608, 1593, 1575, 1521, 1498, 1464, 1409, 1377, 1320, 1279, 1251, 1208, 1196, 1176, 1156, 1110, 1033, 1021, 962, 954, 868, 841, 807, 791, 757, 733, 712, 897; 1H NMR (DMSO-d6) δ 14.19 (s, 1H), 10.37 (s, 1H), 8.31 (d, J = 8.3 Hz, 1H), 8.10 (d, J = 8.9 Hz, 1H), 7.92 (d, J = 8.1 Hz, 1H), 7.68 (t, J = 7.4 Hz, 1H), 7.59 (t, J = 7.5 Hz, 1H), 7.47 (d, J = 8.8 Hz, 1H), 7.23 (d, J = 8.4 Hz, 1H), 6.98 (d, J = 2.2 Hz, 1H), 6.85 (dd, J = 8.4, 2.4 Hz, 1H), 3.76 (s, 3H), 2.19 (s, 3H); 13C-NMR (DMSO-d6), δ: 169.47, 159.88, 157.57, 135.97, 135.92, 130.93, 129.04, 127.52, 126.06, 125.90, 124.70, 123.05, 123.02, 117.90, 112.67, 112.53, 107.27, 55.23, 16.94; HR-MS: for C19H17NO3 [M + H]+ calculated 308.12812 m/z found 308.12842 m/z.

3.3. Lipophilicity Determination by HPLC (Capacity Factor k/Calculated log k)

The HPLC separation module Waters® e2695 equipped with a Waters 2996 PDA Detector (Waters Corp., Milford, MA, USA) was used. A chromatographic column Symmetry® C18 5 μm, 4.6 × 250 mm, Part No. W21751W016 (Waters Corp.) was used. The HPLC separation process was monitored by the Empower 3 Chromatography Data Software (Waters Corp.). Isocratic elution, by a mixture of MeOH p.a. (72%) and H2O-HPLC Mili-Q grade (28%), was used as a mobile phase. The total flow of the column was 1.0 mL/min, the injection was 20 μL, the column temperature was 40 °C, and the sample temperature was 10 °C. A detection wavelength of 210 nm was chosen. A KI methanolic solution was used for the dead time (td) determination. Retention times (tr) were measured in minutes. The capacity factors k were calculated using the Empower 3 Chromatography Data Software, according to the formula k = (trtd)/td, where tR is the retention time of the solute and td is the dead time obtained using an unretained analyte. Each experiment was repeated three times. Log k, calculated from the capacity factor k, is used as the lipophilicity index converted to log P scale [4]. The log k values of individual compounds are shown in Table 1.

3.4. Lipophilicity Calculations

Log P, i.e., the logarithm of the partition coefficient for n-octanol/water, was calculated using the programs ACD/Percepta 2012 (Advanced Chemistry Development, Inc., Toronto, ON, Canada, 2012) and ChemBioDraw Ultra 13.0 (CambridgeSoft, PerkinElmer Inc., Waltham, MA, USA). Clog P values, i.e., the logarithm of the n-octanol/water partition coefficient based on established chemical interactions, were calculated by means of the ChemBioDraw Ultra 13.0 (CambridgeSoft) software. The results are shown in Table 1.

Acknowledgments

This study was supported by grants VEGA 1/0040/17, VEGA 1/0552/18, APVV-17-0373 and APVV-14-0147. The HPLC/HRMS system forms a part of the National Infrastructure CzeCOS ProCES CZ.02.1.01/0.0/0.0/16_013/0001609; Michal Oravec was supported by the National Sustainability Program (NPU I; Grant No. LO1415), and Josef Jampilek was supported by the Ministry of Education of the Czech Republic (LO1305).

References

  1. Lipinski, C.A.; Lombardo, F.; Dominy, B.W.; Feeney, P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 2001, 46, 3–26. [Google Scholar] [CrossRef] [PubMed]
  2. Lipinski, C.A. Lead- and drug-like compounds: The rule-of-five revolution. Drug Discov. Today Technol. 2004, 1, 337–341. [Google Scholar] [CrossRef] [PubMed]
  3. Kerns, E.H.; Di, L. Drug-like Properties: Concepts, Structure Design and Methods: From ADME to Toxicity Optimization; Academic Press: San Diego, CA, USA, 2008. [Google Scholar]
  4. Pliska, V. Volume 4 Methods and Principles in Medicinal Chemistry. In Lipophilicity in Drug Action and Toxicology, 1st ed.; Pliska, V., Testa, B., van der Waterbeemd, H., Eds.; Wiley-VCH: Weinheim, Germany, 1996; pp. 1–6. [Google Scholar]
  5. Kucerova-Chlupacova, M.; Opletalova, V.; Jampilek, J.; Dolezel, J.; Dohnal, J.; Pour, M.; Kunes, J.; Vorisek, V. New hydrophobicity constants of substituents in pyrazine rings derived from RP-HPLC study. Coll. Czechoslov. Chem. Commun. 2008, 73, 1–18. [Google Scholar] [CrossRef]
  6. Musilek, K.; Jampilek, J.; Dohnal, J.; Jun, D.; Gunn-Moore, F.; Dolezal, M.; Kuca, K. RP-HPLC determination of the lipophilicity of bispyridinium reactivators of acetylcholinesterase bearing a but-2-ene connecting linker. Anal. Bioanal. Chem. 2008, 391, 367–372. [Google Scholar] [CrossRef] [PubMed]
  7. Musiol, R.; Jampilek, J.; Podeszwa, B.; Finster, J.; Tabak, D.; Dohnal, J.; Polanski, J. RP-HPLC determination of drug lipophilicity in series of quinoline derivatives. Cent. Eur. J. Chem. 2009, 7, 586–597. [Google Scholar]
  8. Tengler, J.; Kapustikova, I.; Stropnicky, O.; Mokry, P.; Oravec, M.; Csollei, J.; Jampilek, J. Synthesis of New (arylcarbonyloxy)aminopropanol derivatives and the determination of their physico-chemical properties. Cent. Eur. J. Chem. 2013, 11, 1757–1767. [Google Scholar] [CrossRef]
  9. Kapustikova, I.; Bak, A.; Gonec, T.; Kos, J.; Kozik, V.; Jampilek, J. Investigation of Hydro-Lipophilic Properties of N-Alkoxyphenylhydroxynaphthalenecarboxamides. Molecules 2018, 23, 1635. [Google Scholar] [CrossRef]
  10. Gonec, T.; Kos, J.; Zadrazilova, I.; Pesko, M.; Keltosova, S.; Tengler, J.; Bobal, P.; Kollar, P.; Cizek, A.; Kralova, K.; et al. Antimycobacterial and herbicidal activity of ring-substituted 1-hydroxynaphthalene-2-carboxanilides. Bioorg. Med. Chem. 2013, 21, 6531–6541. [Google Scholar] [CrossRef] [PubMed]
  11. Gonec, T.; Pospisilova, S.; Kauerova, T.; Kos, J.; Dohanosova, J.; Oravec, M.; Kollar, P.; Coffey, A.; Liptaj, T.; Cizek, A.; et al. N-Alkoxyphenylhydroxynaphthalene-carboxamides and their antimycobacterial activity. Molecules 2016, 21, 1068. [Google Scholar] [CrossRef] [PubMed]
  12. Gonec, T.; Kralova, K.; Pesko, M.; Jampilek, J. Antimycobacterial N-alkoxyphenyl-hydroxynaphthalene- carboxamides affecting photosystem II. Bioorg. Med. Chem. Lett. 2017, 27, 1881–1885. [Google Scholar] [CrossRef] [PubMed]
  13. Gonec, T.; Kos, J.; Pesko, M.; Dohanosova, J.; Oravec, M.; Liptaj, T.; Kralova, K.; Jampilek, J. Halogenated 1-Hydroxynaphthalene-2-carboxanilides Affecting Photosynthetic Electron Transport in Photosystem II. Molecules 2017, 22, 1709. [Google Scholar] [CrossRef] [PubMed]
  14. Jampilek, J.; Opletalova, V.; Grafnetterova, T.; Dohnal, J. Thiosemicarbazones of acetylpyrazines: Preparation and their hydrophobic properties. In Proceedings of the ECSOC-9, Basel, Switzerland, 1–30 November 2005; p. a001. Available online: http://www.usc.es/congresos/ecsoc/9/GOS/a001/index.htm (accessed on 10 October 2018).
  15. Jampilek, J.; Vinsova, J.; Grafnetterova, T.; Dohnal, J. Synthesis and hydrophobic properties of benzoxazoles. In Proceedings of the ECSOC-9, Basel, Switzerland, 1–30 November 2005; p. a008. Available online: http://www.usc.es/congresos/ecsoc/9/GOS/a008/index.htm (accessed on 10 October 2018).
  16. Opletalova, V.; Jampilek, J.; Chlupacova, M.; Dolezel, J.; Grafnetterova, T.; Dohnal, J. Chromatographic and computational study of hydrophobic properties of ring substituted pyrazinecarbonitriles and acetylpyrazines. In Proceedings of the ECSOC-9, Basel, Switzerland, 1–30 November 2005; p. c004. Available online: http://www.usc.es/congresos/ecsoc/9/BOCNP/c004/index.htm (accessed on 10 October 2018).
  17. Jampilek, J.; Vinsova, J.; Dohnal, J. Synthesis and hydrophobic properties of substituted 2-aryl-5,7-di-tert-butylbenzoxazoles. In Proceedings of the ECSOC-10, Basel, Switzerland, 1–30 November 2006; p. a003. Available online: http://www.usc.es/congresos/ecsoc/10/ECSOC10.htm (accessed on 10 October 2018).
  18. Jampilek, J.; Opletalova, V.; Dohnal, J. N,N-Dimethylthiosemicarbazones of acetylpyrazines: Preparation and their hydrophobic properties. In Proceedings of the ECSOC-10, Basel, Switzerland, 1–30 November 2006; p. a004. Available online: http://www.usc.es/congresos/ecsoc/10/ECSOC10.htm (accessed on 10 October 2018).
  19. Jampilek, J.; Palek, L.; Dolezal, M. Synthesis and hydrophobic properties of some substituted 3-arylaminopyrazine-2,5-dicarbonitriles. In Proceedings of the ECSOC-10, Basel, Switzerland, 1–30 November 2006; p. a019. Available online: http://www.usc.es/congresos/ecsoc/10/ECSOC10.htm (accessed on 10 October 2018).
  20. Jampilek, J.; Vinsova, J.; Kaderavkova, Z.; Dohnal, J. Synthesis and hydrophobic properties of new 2-aryl-5,7-di-tert-butylbenzoxazoles. In Proceedings of the ECSOC-11, Basel, Switzerland, 1–30 November 2007; p. a009. Available online: http://www.usc.es/congresos/ecsoc/11/hall_aGOS/a009/index.htm (accessed on 10 October 2018).
  21. Jampilek, J.; Opletalova, V.; Dolezel, J.; Dohnal, J. Preparation and hydrophobic properties of 5-arylalkylidenerhodanines. In Proceedings of the ECSOC-11, Basel, Switzerland, 1–30 November 2007; p. a012. Available online: http://www.usc.es/congresos/ecsoc/11/hall_aGOS/a012/index.htm (accessed on 10 October 2018).
  22. Dolezal, M.; Jampilek, J.; Bielesz, S.; Kunes, J. Substituted pyrazine-2,5-dicarboxamides: Synthesis, hydrophobicity parameters, and antimycobacterial evaluation. In Proceedings of the ECSOC-11, Basel, Switzerland, 1–30 November 2007; p. c005. Available online: http://www.usc.es/congresos/ecsoc/11/ hall_cBCNP/c005/index.htm (accessed on 10 October 2018).
  23. Opletalova, V.; Jampilek, J.; Dolezel, J.; Hirsova, P.; Dohnal, J. Rhodanineacetic acid derivatives as potential drugs: Preparation and hydrophobic properties of 5-arylalkylidene-3-carboxymethylrhodanines. In Proceedings of the ECSOC-12, Basel, Switzerland, 1–30 November 2008; p. c0006. Available online: http://www.usc.es/congresos/ecsoc/12/ECSOC12.htm (accessed on 10 October 2018).
  24. Kapustikova, I.; Gonec, T.; Kos, J.; Jampilek, J. Chromatographic and computational study of hydro-lipophilic properties of N-alkoxyphenylhydroxynaphthalenecarboxamides. In Proceedings of the ECSOC-12, Basel, Switzerland, 1–30 November 2008; p. 4719. Available online: http://sciforum.net/conference/ecsoc-21/paper/4719 (accessed on 10 October 2018).
Scheme 1. Synthesis of ring-substituted 1-hydroxynaphthalene-2-carboxanilides 117. Reagents and conditions: (a) PCl3, chlorobenzene, MW, 15 min. [10,11,13].
Scheme 1. Synthesis of ring-substituted 1-hydroxynaphthalene-2-carboxanilides 117. Reagents and conditions: (a) PCl3, chlorobenzene, MW, 15 min. [10,11,13].
Proceedings 09 00043 sch001
Figure 1. Comparison of experimentally-found log k values with calculated log P (ACD/Percepta) of N-methoxyphenyl-1-hydroxynaphthalene-2-carboxanilides 27.
Figure 1. Comparison of experimentally-found log k values with calculated log P (ACD/Percepta) of N-methoxyphenyl-1-hydroxynaphthalene-2-carboxanilides 27.
Proceedings 09 00043 g001
Figure 2. Comparison of experimentally-found log k values with calculated Clog P (ChemBioDraw) of N-methoxyphenyl-1-hydroxynaphthalene-2-carboxanilides 27 (A), N-methylphenyl-1-hydroxy- naphthalene-2-carboxanilides 814 (B) and methoxymethyl derivatives 1517 (C).
Figure 2. Comparison of experimentally-found log k values with calculated Clog P (ChemBioDraw) of N-methoxyphenyl-1-hydroxynaphthalene-2-carboxanilides 27 (A), N-methylphenyl-1-hydroxy- naphthalene-2-carboxanilides 814 (B) and methoxymethyl derivatives 1517 (C).
Proceedings 09 00043 g002
Figure 3. Comparison of experimentally-determined log k values of N-methoxy and N-methyl substituted compounds.
Figure 3. Comparison of experimentally-determined log k values of N-methoxy and N-methyl substituted compounds.
Proceedings 09 00043 g003
Table 1. Structure of N-substituted 1-hydroxynaphthalene-2-carboxanilides 117, calculated lipophilicities (log P/Clog P) and experimentally determined log k values of investigated compounds.
Table 1. Structure of N-substituted 1-hydroxynaphthalene-2-carboxanilides 117, calculated lipophilicities (log P/Clog P) and experimentally determined log k values of investigated compounds.
Proceedings 09 00043 i001
Comp.Rlog klog P (ACD)log P (ChemBioDraw)Clog P (ChemBioDraw)
1H0.67694.523.454.4462
22-OCH30.85844.613.323.9316
33-OCH30.67134.563.324.5216
44-OCH30.62844.373.324.5216
52,5-OCH30.87124.773.193.95634
63,5-OCH30.70484.493.194.54634
73,4,5-OCH30.56034.303.073.80643
82-CH30.56504.853.934.2952
93-CH30.82354.853.934.9452
104-CH30.82944.853.934.9452
112,5-CH30.71555.034.424.7942
122,6-CH30.59905.114.424.1442
133,5-CH31.00305.034.425.4442
142,4,6-CH30.74775.214.914.6432
152-OCH3-5-CH31.06034.893.814.4306
162-OCH3-6-CH30.45744.893.813.7806
175-OCH3-2-CH30.53624.993.814.3706

Share and Cite

MDPI and ACS Style

Kapustikova, I.; Gonec, T.; Kos, J.; Spaczynska, E.; Oravec, M.; Dohanosova, J.; Liptaj, T.; Musiol, R.; Jampilek, J. Preparation and Hydro-Lipophilic Properties of Methoxylated and Methylated 1-Hydroxynaphthalene-2-Carboxanilides. Proceedings 2019, 9, 43. https://doi.org/10.3390/ecsoc-22-05660

AMA Style

Kapustikova I, Gonec T, Kos J, Spaczynska E, Oravec M, Dohanosova J, Liptaj T, Musiol R, Jampilek J. Preparation and Hydro-Lipophilic Properties of Methoxylated and Methylated 1-Hydroxynaphthalene-2-Carboxanilides. Proceedings. 2019; 9(1):43. https://doi.org/10.3390/ecsoc-22-05660

Chicago/Turabian Style

Kapustikova, Iva, Tomas Gonec, Jiri Kos, Ewelina Spaczynska, Michal Oravec, Jana Dohanosova, Tibor Liptaj, Robert Musiol, and Josef Jampilek. 2019. "Preparation and Hydro-Lipophilic Properties of Methoxylated and Methylated 1-Hydroxynaphthalene-2-Carboxanilides" Proceedings 9, no. 1: 43. https://doi.org/10.3390/ecsoc-22-05660

Article Metrics

Back to TopTop